Abstract
Calcitonin gene-related peptide (CGRP) has many reported pharmacological actions. Can a single receptor explain all of these? This chapter outlines the molecular nature of reported CGRP binding proteins and their pharmacology. Consideration of whether CGRP has only one or has more receptors is important because of the key role that this peptide plays in migraine. It is widely thought that the calcitonin receptor-like receptor together with receptor activity-modifying protein 1 (RAMP1) is the only relevant receptor for CGRP. However, some closely related receptors also have high affinity for CGRP and it is still plausible that these play a role in CGRP biology, and in migraine. The calcitonin receptor/RAMP1 complex, which is currently called the AMY1 receptor, seems to be the most likely candidate but more investigation is needed to determine its role.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y (1996) A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 271(19):11325–11329
Aiyar N, Disa J, Ao Z, Xu D, Surya A, Pillarisetti K, Parameswaran N, Gupta SK, Douglas SA, Nambi P (2002) Molecular cloning and pharmacological characterization of bovine calcitonin receptor-like receptor from bovine aortic endothelial cells. Biochem Pharmacol 63(11):1949–1959
Bailey RJ, Walker CS, Ferner AH, Loomes KM, Prijic G, Halim A, Whiting L, Phillips ARJ, Hay DL (2012) Pharmacological characterisation of rat amylin receptors: implications for the identification of amylin receptor subtypes. Br J Pharmacol 166(1):151–167. https://doi.org/10.1111/j.1476-5381.2011.01717.x
Booe JM, Walker CS, Barwell J, Kuteyi G, Simms J, Jamaluddin MA, Warner ML, Bill RM, Harris PW, Brimble MA, Poyner DR, Hay DL, Pioszak AA (2015) Structural basis for receptor activity-modifying protein-dependent selective peptide recognition by a G protein-coupled receptor. Mol Cell 58(6):1040–1052. https://doi.org/10.1016/j.molcel.2015.04.018
Chakravarty P, Suthar TP, Coppock HA, Nicholl CG, Bloom SR, Legon S, Smith DM (2000) CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br J Pharmacol 130(1):189–195
Christopoulos G, Perry K, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, Main MJ, Foord SM, Sexton PM (1999) Multiple amylin receptors arise from receptor-activity-modifying-proteins interaction with the calcitonin receptor gene product. Mol Pharmacol 56:235–242
Dennis T, Fournier A, Cadieux A, Pomerleau F, Jolicoeur FB, St. Pierre S, Quirion R (1990) hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther 254(1):123–128
Elshourbagy NA, Adamou JE, Swift AM, Disa J, Mao J, Ganguly S, Bergsma DJ, Aiyar N (1998) Molecular cloning and characterization of the porcine calcitonin gene-related peptide receptor. Endocrinology 139(4):1678–1683
Fluhmann B, Muff R, Hunziker W, Fischer JA, Born W (1995) A human orphan calcitonin receptor-like structure. Biochem Biophys Res Commun 206(1):341–347
Foord SM, Wise A, Brown J, Main MJ, Fraser NJ (1999) The N-terminus of RAMPs is a critical determinant of the glycosylation state and ligand binding of calcitonin receptor-like receptor. Biochem Soc Trans 27(4):535–539
Fraser NJ, Wise A, Brown J, McLatchie LM, Main MJ, Foord SM (1999) The amino terminus of receptor activity modifying proteins is a crucial determinant of glycosylation state and ligand binding of calcitonin-receptor-like-receptor. Mol Pharmacol 55:1054–1059
Furness SGB, Wootten D, Christopoulos A, Sexton PM (2012) Consequences of splice variation on secretin family G protein-coupled receptor function. Br J Pharmacol 166(1):98–109. https://doi.org/10.1111/j.1476-5381.2011.01571.x
Halim A, Hay DL (2012) The role of glutamic acid 73 in adrenomedullin interactions with rodent AM2 receptors. Peptides 36(1):137–141. https://doi.org/10.1016/j.peptides.2012.04.011
Han ZQ, Coppock HA, Smith DM, Van Noorden S, Makgoba MW, Nicholl CG, Legon S (1997) The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium. J Mol Endocrinol 18(3):267–272
Hanze J, Dittrich K, Dotsch J, Rascher W (1997) Molecular cloning of a novel human receptor gene with homology to the rat adrenomedullin receptor and high expression in heart and immune system. Biochem Biophys Res Commun 240(1):183–188
Hay DL, Walker CS (2017) CGRP and its receptors. Headache 57(4):625–636. https://doi.org/10.1111/head.13064
Hay DL, Howitt SG, Conner AC, Doods H, Schindler M, Poyner DR (2002) A comparison of the actions of BIBN4096BS and CGRP8-37 on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells. Br J Pharmacol 137(1):80
Hay DL, Howitt SG, Conner AC, Schindler M, Smith DM, Poyner DR (2003) CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS. Br J Pharmacol 140(3):477–486
Hay DL, Christopoulos G, Christopoulos A, Poyner DR, Sexton PM (2005) Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Mol Pharmacol 67(5):1655–1665. https://doi.org/10.1124/mol.104.008615
Hay DL, Christopoulos G, Christopoulos A, Sexton PM (2006) Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-d ibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazoliny l) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors – the role of receptor activity modifying protein 1. Mol Pharmacol 70(6):1984–1991. https://doi.org/10.1124/mol.106.027953
Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD (2015) Amylin: pharmacology, physiology, and clinical potential. Pharmacol Rev 67(3):564–600. https://doi.org/10.1124/pr.115.010629
Hay DL, Garelja ML, Poyner DR, Walker CS (2018) Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR review 25. Br J Pharmacol 175(1):3–17. https://doi.org/10.1111/bph.14075
Husmann K, Sexton PM, Fischer JA, Born W (2000) Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function. Mol Cell Endocrinol 162(1–2):35–43
Juaneda C, Dumont Y, Quirion R (2000) The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci 21:432–438
Kapas S, Clark AJ (1995) Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor. Biochem Biophys Res Commun 217(3):832–838
Kapas S, Catt KJ, Clark AJ (1995) Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J Biol Chem 270(43):25344–25347
Kennedy SP, Sun D, Oleynek JJ, Hoth CF, Kong J, Hill RJ (1998) Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response. Biochem Biophys Res Commun 244:832–837
Klein KR, Karpinich NO, Espenschied ST, Willcockson HH, Dunworth WP, Hoopes SL, Kushner EJ, Bautch VL, Caron KM (2014) Decoy receptor CXCR7 modulates adrenomedullin-mediated cardiac and lymphatic vascular development. Dev Cell 30(5):528–540. https://doi.org/10.1016/j.devcel.2014.07.012
Kusano S, Kukimoto-Niino M, Hino N, Ohsawa N, Okuda K-I, Sakamoto K, Shirouzu M, Shindo T, Yokoyama S (2012) Structural basis for extracellular interactions between calcitonin receptor-like receptor and receptor activity-modifying protein 2 for adrenomedullin-specific binding. Protein Sci 21(2):199–210. https://doi.org/10.1002/pro.2003
Kuwasako K, Cao Y-N, Nagoshi Y, Tsuruda T, Kitamura K, Eto T (2004) Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins. Mol Pharmacol 65(1):207–213
Leuthauser K, Gujer R, Aldecoa A, McKinney RA, Muff R, Fischer JA, Born W (2000) Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition. Biochem J 351:347–351
Luebke AE, Dahl GP, Roos BA, Dickerson IM (1996) Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay. Proc Natl Acad Sci U S A 93(8):3455–3460
McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393(6683):333–339
Miyauchi K, Tadotsu N, Hayashi T, Ono Y, Tokoyoda K, Tsujikawa K, Yamamoto H (2002) Molecular cloning and characterization of mouse calcitonin gene-related peptide receptor. Neuropeptides 36(1):22–33
Moore EL, Salvatore CA (2012) Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine. Br J Pharmacol 166(1):66–78. https://doi.org/10.1111/j.1476-5381.2011.01633.x
Nagae T, Mukoyama M, Sugawara A, Mori K, Yahata K, Kasahara M, Suganami T, Makino H, Fujinaga Y, Yoshioka T, Tanaka K, Nakao K (2000) Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy. Biochem Biophys Res Commun 270:89–93
Njuki F, Nicholl CG, Howard A, Mak JCW, Barnes PJ, Girgis SI, Legon S (1993) A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin Sci 85:385–388
Oliver KR, Kane SA, Salvatore CA, Mallee JJ, Kinsey AM, Koblan KS, Keyvan-Fouladi N, Heavens RP, Wainwright A, Jacobson M, Dickerson IM, Hill RG (2001) Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur J Neurosci 14(4):618–628. https://doi.org/10.1046/j.0953-816x.2001.01688.x
Poyner D (1995) Pharmacology of receptors for calcitonin gene-related peptide and amylin. Trends Pharmacol Sci 16(12):424–428
Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, Adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54(2):233–246
Qi T, Dong M, Watkins HA, Wootten D, Miller LJ, Hay DL (2013) Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Δ(1–47)hCT(a) function. Br J Pharmacol 168(3):644–657. https://doi.org/10.1111/j.1476-5381.2012.02197.x
ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA, Lepre CA, Garcia-Guzman M, Moore JM (2010) Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18(9):1083–1093. https://doi.org/10.1016/j.str.2010.05.014
Salvatore CA, Moore EL, Calamari A, Cook JJ, Michener MS, O’Malley S, Miller PJ, Sur C, Williams DL Jr, Zeng Z, Danziger A, Lynch JJ, Regan CP, Fay JF, Tang YS, Li CC, Pudvah NT, White RB, Bell IM, Gallicchio SN, Graham SL, Selnick HG, Vacca JP, Kane SA (2010) Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist. J Pharmacol Exp Ther 333(1):152–160. https://doi.org/10.1124/jpet.109.163816
Sekiguchi T, Kuwasako K, Ogasawara M, Takahashi H, Matsubara S, Osugi T, Muramatsu I, Sasayama Y, Suzuki N, Satake H (2016) Evidence for conservation of the calcitonin superfamily and activity-regulating mechanisms in the basal chordate Branchiostoma floridae: insights into the molecular and functional evolution in chordates. J Biol Chem 291(5):2345–2356. https://doi.org/10.1074/jbc.M115.664003
Shi L, Lehto SG, Zhu DXD, Sun H, Zhang J, Smith BP, Immke DC, Wild KD, Xu C (2016) Pharmacologic characterization of AMG 334, a potent and selective human monoclonal antibody against the calcitonin gene-related peptide receptor. J Pharmacol Exp Ther 356(1):223–231. https://doi.org/10.1124/jpet.115.227793
Suzuki N, Suzuki T, Kurokawa T (2000) Cloning of a calcitonin gene-related peptide receptor and a novel calcitonin receptor-like receptor from the gill of the flounder, Paralichthys olivaceus. Gene 244:81–88
Tilakaratne N, Christopoulos G, Zumpe ET, Foord SM, Sexton PM (2000) Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. J Pharmacol Exp Ther 294:61–72
Walker CS, Conner AC, Poyner DR, Hay DL (2010) Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol Sci 31(10):476–483. https://doi.org/10.1016/j.tips.2010.06.006
Walker CS, Eftekhari S, Bower RL, Wilderman A, Insel PA, Edvinsson L, Waldvogel HJ, Jamaluddin MA, Russo AF, Hay DL (2015) A second trigeminal CGRP receptor: function and expression of the AMY1 receptor. Ann Clin Transl Neurol 2(6):595–608. https://doi.org/10.1002/acn3.197
Walker CS, Raddant AC, Woolley MJ, Russo AF, Hay DL (2017) CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured. Cephalalgia 38(3):437–451. https://doi.org/10.1177/0333102417691762
Watkins HA, Rathbone DL, Barwell J, Hay DL, Poyner DR (2013) Structure-activity relationships for alpha-calcitonin gene-related peptide. Br J Pharmacol 170(7):1308–1322. https://doi.org/10.1111/bph.12072
Weston C, Winfield I, Harris M, Hodgson R, Shah A, Dowell SJ, Mobarec JC, Woodlock DA, Reynolds CA, Poyner DR, Watkins HA, Ladds G (2016) Receptor activity-modifying protein-directed G protein signaling specificity for the calcitonin gene-related peptide family of receptors. J Biol Chem 291(42):21925–21944. https://doi.org/10.1074/jbc.M116.751362
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Hay, D.L. (2018). CGRP Receptor Biology: Is There More Than One Receptor?. In: Brain, S., Geppetti, P. (eds) Calcitonin Gene-Related Peptide (CGRP) Mechanisms. Handbook of Experimental Pharmacology, vol 255. Springer, Cham. https://doi.org/10.1007/164_2018_131
Download citation
DOI: https://doi.org/10.1007/164_2018_131
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21453-1
Online ISBN: 978-3-030-21454-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)